Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (481-490 of 1,560) with videos related to

Pageof 156
Sort By:
Cardiology in Review|June 16, 2009
Cardiac manifestations of sarcoidosis and therapeutic optionsBredy Pierre-Louis, Aakanksha Prasad, William H Frishman
Progress in Cardiovascular Diseases|January 1, 1997
Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related proceduresB R Landzberg, W H Frishman, K Lerrick
Journal of Clinical Pharmacology|July 1, 1996
Nicorandil: a potassium channel opening drug for treatment of ischemic heart diseaseM Goldschmidt, B R Landzberg, W H Frishman
Proteins|February 27, 2010
Current status of membrane protein structure classificationSindy Neumann, Angelika Fuchs, Armen Mulkidjanian, et al.
American Journal of Hypertension|April 4, 2006
A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT)William H Frishman, James W Hainer, Jennifer Sugg, et al.
Cardiology in Review|January 23, 2023
Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?Joel Novograd, Jamie A Mullally, William H Frishman
Cardiology in Review|July 15, 2021
Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019Tzvi Fishkin, Michael D Goldberg, William H Frishman
Cardiology in Review|July 5, 2021
Cholesterol Paradigm and Beyond in Atherosclerotic Cardiovascular Disease: Cholesterol, Sterol Regulatory Element-Binding Protein, Inflammation, and Vascular Cell Mobilization in VasculopathyRuihai Zhou, George A Stouffer, William H Frishman
Plos One|November 9, 2013
Classification of α-helical membrane proteins using predicted helix architecturesSindy Neumann, Angelika Fuchs, Barbara Hummel, et al.
Cardiology in Review|February 11, 2020
Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation TherapyDaniel Glicklich, Christopher T Shin, William H Frishman
Pageof 156

Showing results (481-490 of 1,560) with videos related to

Sort By:
Pageof 156
Cardiology in Review|June 16, 2009
Cardiac manifestations of sarcoidosis and therapeutic optionsBredy Pierre-Louis, Aakanksha Prasad, William H Frishman
Progress in Cardiovascular Diseases|January 1, 1997
Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related proceduresB R Landzberg, W H Frishman, K Lerrick
Journal of Clinical Pharmacology|July 1, 1996
Nicorandil: a potassium channel opening drug for treatment of ischemic heart diseaseM Goldschmidt, B R Landzberg, W H Frishman
Proteins|February 27, 2010
Current status of membrane protein structure classificationSindy Neumann, Angelika Fuchs, Armen Mulkidjanian, et al.
American Journal of Hypertension|April 4, 2006
A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT)William H Frishman, James W Hainer, Jennifer Sugg, et al.
Cardiology in Review|January 23, 2023
Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?Joel Novograd, Jamie A Mullally, William H Frishman
Cardiology in Review|July 15, 2021
Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019Tzvi Fishkin, Michael D Goldberg, William H Frishman
Cardiology in Review|July 5, 2021
Cholesterol Paradigm and Beyond in Atherosclerotic Cardiovascular Disease: Cholesterol, Sterol Regulatory Element-Binding Protein, Inflammation, and Vascular Cell Mobilization in VasculopathyRuihai Zhou, George A Stouffer, William H Frishman
Plos One|November 9, 2013
Classification of α-helical membrane proteins using predicted helix architecturesSindy Neumann, Angelika Fuchs, Barbara Hummel, et al.
Cardiology in Review|February 11, 2020
Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation TherapyDaniel Glicklich, Christopher T Shin, William H Frishman
Pageof 156